The new moiety called NGR-TNF was shown to transiently enhance tumor vessel permeability (45), thus increasing the penetration of chemotherapy agents in murine models of lymphoma, melanoma, and spontaneous prostate cancer without TNF-related systemic toxicity (46, 47). The gene discussed is TNF; the disease is neoplasm.